To put the blood of youth into the veins to ensure eternity. The challenge that is luring the rich
The quest for the elixir of eternal youth knows no bounds. The first person who wanted to challenge the passage of time with extreme practice was Bryan Johnson. For months, the 46-year-old Utah-born American billionaire had paid hundreds of thousands of dollars to inject his 17-year-old son Talmage's plasma into his veins. Johnson also injected the boy's plasma into his grandfather's body, hoping to slow his physical and cognitive decline.
Today the billionaire himself admits that the therapy was a failure. And he says enough of these transfusions: "They don't work - he declared - the exchange of young plasma can be useful for biologically older populations or under certain conditions."
But this failure has not made the billionaire stop.
Braintree's founder continues to fund research at $2 million a year to identify ways to live longer.
And in Silicon Valley, algorithms and AI are even used to prolong a body's youth.